WO2008014314A3 - Biomarkers of mild cognitive impairment and alzheimer's disease - Google Patents
Biomarkers of mild cognitive impairment and alzheimer's disease Download PDFInfo
- Publication number
- WO2008014314A3 WO2008014314A3 PCT/US2007/074309 US2007074309W WO2008014314A3 WO 2008014314 A3 WO2008014314 A3 WO 2008014314A3 US 2007074309 W US2007074309 W US 2007074309W WO 2008014314 A3 WO2008014314 A3 WO 2008014314A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- alzheimer
- prostaglandin
- isomerase
- cognitive impairment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002658895A CA2658895A1 (en) | 2006-07-25 | 2007-07-25 | Biomarkers of mild cognitive impairment and alzheimer's disease |
AU2007279287A AU2007279287B2 (en) | 2006-07-25 | 2007-07-25 | Biomarkers of mild cognitive impairment and Alzheimer's disease |
EP07840505A EP2054724B1 (en) | 2006-07-25 | 2007-07-25 | Biomarkers of mild cognitive impairment and alzheimer's disease |
AT07840505T ATE523785T1 (en) | 2006-07-25 | 2007-07-25 | BIOMARRKERS FOR MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/459,763 | 2006-07-25 | ||
US11/459,763 US7851172B2 (en) | 2006-07-25 | 2006-07-25 | Biomarkers of mild cognitive impairment and alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008014314A2 WO2008014314A2 (en) | 2008-01-31 |
WO2008014314A3 true WO2008014314A3 (en) | 2008-10-23 |
Family
ID=38982288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/074309 WO2008014314A2 (en) | 2006-07-25 | 2007-07-25 | Biomarkers of mild cognitive impairment and alzheimer's disease |
Country Status (6)
Country | Link |
---|---|
US (2) | US7851172B2 (en) |
EP (2) | EP2054724B1 (en) |
AT (1) | ATE523785T1 (en) |
AU (1) | AU2007279287B2 (en) |
CA (1) | CA2658895A1 (en) |
WO (1) | WO2008014314A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG187453A1 (en) | 2008-01-18 | 2013-02-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
US9968574B2 (en) * | 2009-05-15 | 2018-05-15 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
WO2010133173A1 (en) * | 2009-05-21 | 2010-11-25 | Rongxiu Li | Process for differential polypeptides detection and uses thereof |
WO2017120461A1 (en) | 2016-01-08 | 2017-07-13 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
US20140154668A1 (en) | 2010-05-21 | 2014-06-05 | The Trustees Of Princeton University | Structures for Enhancement of Local Electric Field, Light Absorption, Light Radiation, Material Detection and Methods for Making and Using of the Same. |
CN105911814A (en) | 2010-05-21 | 2016-08-31 | 普林斯顿大学 | Structures for enhancement of local electric field, light absorption, light radiation material detection and methods for making and using of the same |
CA2806293A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
MX2013000917A (en) | 2010-07-23 | 2013-07-05 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells. |
US20120053073A1 (en) | 2010-07-23 | 2012-03-01 | President And Fellows Of Harvard College | Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids |
CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
LT2683419T (en) | 2011-03-11 | 2018-07-25 | Vib Vzw | Molecules and methods for inhibition and detection of proteins |
US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
WO2013010170A1 (en) | 2011-07-14 | 2013-01-17 | Lovell Mark A | Process for detection of alzheimer's disease from a serum sample |
EP2836821B1 (en) * | 2012-04-10 | 2018-09-26 | The Trustees of Princeton University | Ultra-sensitive sensor |
MX358474B (en) | 2012-04-13 | 2018-08-21 | Oasis Diagnostics Corp | Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases. |
US20140179805A1 (en) | 2012-06-15 | 2014-06-26 | Harry Stylli | Methods of detecting diseases or conditions |
CA2876711A1 (en) | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions using circulating diseased cells |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
EP2965077B1 (en) | 2013-03-09 | 2022-07-13 | Harry Stylli | Methods of detecting cancer |
CN105229467A (en) * | 2013-03-15 | 2016-01-06 | 普林斯顿大学理事会 | Quick and sensitive analysis measurement determination method |
SG11201510701QA (en) * | 2013-06-28 | 2016-01-28 | Mcbi Inc | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers |
US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
KR102155857B1 (en) | 2013-12-09 | 2020-09-15 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Methods and compositions for treating aging-associated conditions |
AU2015314813B2 (en) | 2014-09-11 | 2022-02-24 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
DK3307296T3 (en) | 2015-06-15 | 2021-12-13 | Univ Leland Stanford Junior | TIMP2 FOR USE IN THE TREATMENT OF AGING ASSOCIATED CONDITIONS |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004001421A2 (en) * | 2002-06-21 | 2003-12-31 | Innogenetics N.V. | Method for the diagnosis and differential diagnosis of neurological diseases |
WO2006108051A2 (en) * | 2005-04-05 | 2006-10-12 | Neurodx, Llc | Compositions and methods relating to alzheimer's disease |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4278605A (en) * | 1980-06-30 | 1981-07-14 | American Cyanamid Company | Heteroalkylenebisanthraquinones |
US4728605A (en) | 1984-07-31 | 1988-03-01 | Fudenberg Herman H | Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same |
JP3265577B2 (en) | 1992-10-13 | 2002-03-11 | デューク・ユニバーシティ | Method for measuring type 4 isoform of apolipoprotein E |
EP0760098A4 (en) | 1994-06-09 | 1997-07-16 | Univ Bar Ilan | Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions |
US5686269A (en) | 1994-07-28 | 1997-11-11 | The Mclean Hospital Corporation | Method of diagnosing Alzheimer's disease by detecting the level of cathepsin D in cerebrospinal fluid |
US6114133A (en) | 1994-11-14 | 2000-09-05 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) |
CN1148600C (en) * | 1996-11-26 | 2004-05-05 | 三星电子株式会社 | Liquid crystal display using organic insulating material and manufacturing methods thereof |
AUPO943297A0 (en) | 1997-09-24 | 1997-10-16 | University Of Melbourne, The | Diagnostic test for alzheimer's disease |
US6358681B2 (en) | 1998-10-30 | 2002-03-19 | The Trustees Of The University Of Pennsylvania | Diagnostic methods for alzheimer's disease by detection of multiple mRNAs |
CA2269432C (en) | 1998-06-01 | 2002-04-02 | Hyman M. Schipper | Ho-1 as a diagnostic and prognostic test for dementing diseases |
US6458549B2 (en) | 1998-06-11 | 2002-10-01 | Winthrop-University Hospital | Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same |
AU2610901A (en) | 1999-12-30 | 2001-07-16 | Washington University | Predictive diagnostic for alzheimer's disease |
US6495335B2 (en) | 2000-12-07 | 2002-12-17 | Mario Chojkier | Compositions and methods for diagnosing alzheimer's disease |
US6475161B2 (en) | 2001-03-29 | 2002-11-05 | The Mclean Hospital Corporation | Methods for diagnosing Alzheimer's disease and other forms of dementia |
US6451547B1 (en) | 2001-04-25 | 2002-09-17 | Syn X Pharma | Process for differential diagnosis of Alzheimer's dementia and device therefor |
EP1694816B1 (en) | 2003-11-07 | 2013-08-28 | Ciphergen Biosystems, Inc. | Biomarkers for alzheimer's disease |
EP2211183B1 (en) | 2003-11-19 | 2013-03-06 | Satoris, Inc. | Method for diagnosis and monitoring of Alzheimer's disease |
KR20100036324A (en) * | 2005-02-19 | 2010-04-07 | 주식회사 피플바이오 | Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides |
-
2006
- 2006-07-25 US US11/459,763 patent/US7851172B2/en not_active Expired - Fee Related
-
2007
- 2007-07-25 CA CA002658895A patent/CA2658895A1/en not_active Abandoned
- 2007-07-25 WO PCT/US2007/074309 patent/WO2008014314A2/en active Application Filing
- 2007-07-25 AU AU2007279287A patent/AU2007279287B2/en not_active Ceased
- 2007-07-25 AT AT07840505T patent/ATE523785T1/en not_active IP Right Cessation
- 2007-07-25 EP EP07840505A patent/EP2054724B1/en not_active Not-in-force
- 2007-07-25 EP EP11005689A patent/EP2388591A3/en not_active Withdrawn
-
2010
- 2010-11-08 US US12/941,721 patent/US20110104724A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004001421A2 (en) * | 2002-06-21 | 2003-12-31 | Innogenetics N.V. | Method for the diagnosis and differential diagnosis of neurological diseases |
WO2006108051A2 (en) * | 2005-04-05 | 2006-10-12 | Neurodx, Llc | Compositions and methods relating to alzheimer's disease |
Non-Patent Citations (1)
Title |
---|
STARK M. ET AL, JOURNAL OF CHROMATOGRAPHY B : BIOMEDICAL APPLICATIONS, vol. 754, no. 2, 2001, pages 357 - 367, XP004232820 * |
Also Published As
Publication number | Publication date |
---|---|
EP2054724B1 (en) | 2011-09-07 |
AU2007279287A1 (en) | 2008-01-31 |
WO2008014314A2 (en) | 2008-01-31 |
EP2054724A4 (en) | 2009-10-28 |
EP2054724A2 (en) | 2009-05-06 |
ATE523785T1 (en) | 2011-09-15 |
CA2658895A1 (en) | 2008-01-31 |
EP2388591A3 (en) | 2012-04-25 |
US7851172B2 (en) | 2010-12-14 |
US20110104724A1 (en) | 2011-05-05 |
AU2007279287B2 (en) | 2013-01-17 |
EP2388591A2 (en) | 2011-11-23 |
US20080026405A1 (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008014314A3 (en) | Biomarkers of mild cognitive impairment and alzheimer's disease | |
NZ716924A (en) | Biomarkers for the diagnosis and/or prediction of susceptibility to mental and neurodegenerative disorders | |
WO2010061283A8 (en) | Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis | |
WO2007082154A3 (en) | B7-h1 and b7-h4 in cancer | |
WO2008039769A3 (en) | Methods and devices for analyzing small rna molecules | |
WO2008039946A3 (en) | Integrated meter for analyzing biological samples | |
WO2008084331A3 (en) | Biomarkers for renal disorders | |
DE602007011566D1 (en) | Ankheit | |
WO2006108112A3 (en) | System and method for identifying molecules | |
WO2008042760A3 (en) | Method and system for dynamically updating calibration parameters for an analyte sensor | |
EP1776470A4 (en) | Reagents, kits and methods for immunodetection of epitopes on molecules | |
WO2010135574A3 (en) | Systems and methods for determining the percentage of glycated hemoglobin | |
WO2010065781A3 (en) | Lateral flow strip assay with immobilized conjugate | |
WO2008007242A3 (en) | Increased specificity of analyte detection by measurement of bound and unbound labels | |
WO2007092173A3 (en) | Raman spectroscopic lateral flow test strip assays | |
WO2008063770A3 (en) | Reducing optical interference in a fluidic device | |
WO2009026381A3 (en) | Method, computer program product and system for individual assessment of alcohol sensitivity | |
WO2007114986A3 (en) | Cooperative probes and methods of using them | |
WO2010045490A3 (en) | Human biomarker hypermapping for depressive disorders | |
WO2007003801A3 (en) | Method and system for measuring and examining reactor fouling | |
WO2007030206A3 (en) | Method and apparatus for gas measurement at substantially constant pressure | |
WO2007106762A3 (en) | Alzheimer's disease biomarkers and methods of use | |
WO2007085827A3 (en) | Epigenetic analyses | |
WO2008050291A3 (en) | Quantitative measurement of glycated hemoglobin | |
WO2007126882A3 (en) | Analysis of splice variant expression data |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07840505 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2658895 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007279287 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007840505 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
ENP | Entry into the national phase |
Ref document number: 2007279287 Country of ref document: AU Date of ref document: 20070725 Kind code of ref document: A |